Elizabeth Thompson

Safety and Clinical Activity of the Programmed Death-Ligand 1 Inhibitor Durvalumab in Combination With Poly (ADP-Ribose) Polymerase Inhibitor Olaparib or Vascular Endothelial Growth Factor Receptor 1-3 Inhibitor Cediranib in Women's Cancers: A Dose-Escalation, Phase I Study

Jung Min Lee, Ashley Cimino‐Mathews, Cody J. Peer et al. · Journal of Clinical Oncology · 2017 · 235 citations · Full text

Immunology, Olaparib Tablets, Pharmacotherapy +20

High Coronary Shear Stress in Patients With Coronary Artery Disease Predicts Myocardial Infarction

Arnav Kumar, Elizabeth Thompson, Adrien Lefieux et al. · Journal of the American College of Cardiology · 2018 · 169 citations · Full text

Cardiovascular Disease, Stress, Myocardial Infarction +8

Cardiovascular Stress Associated With Concentric and Eccentric Isokinetic Exercise in Young and Older Adults

Tom J. Overend, Theo Versteegh, Elizabeth Thompson et al. · The Journals of Gerontology Series A · 2000 · 109 citations · Full text

Physical Activity, Aging, Exercise Rehabilitation +19

Low Coronary Wall Shear Stress Is Associated With Severe Endothelial Dysfunction in Patients With Nonobstructive Coronary Artery Disease

Arnav Kumar, Olivia Y. Hung, Marina Piccinelli et al. · JACC: Cardiovascular Interventions · 2018 · 89 citations

Vascular Disease, Cardiovascular Disease, Coronary Artery Disease +9

Phase I Study of the Farnesyltransferase Inhibitor Lonafarnib with Paclitaxel in Solid Tumors

Fadlo R. Khuri, Bonnie S. Glisson, Edward S. Kim et al. · Clinical Cancer Research · 2004 · 77 citations